Cypherpunk Technologies Stock (NASDAQ:CYPH)

Forecast Financials Chart

Previous Close

$0.71

52W Range

$0.26 - $3.70

50D Avg

$0.68

200D Avg

$0.92

Market Cap

$85.75M

Avg Vol (3M)

$3.78M

Beta

0.06

Div Yield

-

CYPH Company Profile

Cypherpunk Technologies Inc. is a privacy-focused technology company that combines a digital asset treasury strategy centered on Zcash (ZEC) with the development of novel cancer therapies through its subsidiary. The company's mission is to advance technologies that guarantee privacy for individuals on the internet, with a primary focus on investing in, accelerating the adoption of, and strengthening the ecosystem of Zcash, a privacy-preserving digital currency.

Industry

Asset Management

Sector

Financial Services

Exchange

NASDAQ

ADR

-

Country

US

Employees

6

IPO Date

Jan 25, 2017

Website

CYPH Performance

CYPH Financial Summary

	Dec 25	Dec 24	Dec 23
Revenue	-	-	-
Operating Income	$-41.07M	$-70.06M	$-87.04M
Net Income	$15.33M	$-67.56M	$-81.41M
EBITDA	$-41.07M	$-70.05M	$-80.99M
Basic EPS	$0.07	$-1.81	$-3.98
Diluted EPS	$0.07	$-1.81	$-3.98

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q2 15Aug 05, 15 | 9:00 AM

Q1 15May 12, 15 | 9:00 AM

Q4 14Mar 18, 15 | 9:00 AM

Peer Comparison

Ticker	Company
ASBP	Aspire Biopharma Holdings, Inc.
DARE	Dare Bioscience, Inc.
ICU	SeaStar Medical Holding Corporation
PCSA	Processa Pharmaceuticals, Inc.
ATHA	Athira Pharma, Inc.
CRIS	Curis, Inc.
BCTX	BriaCell Therapeutics Corp.
APLM	Apollomics, Inc.
CTXR	Citius Pharmaceuticals, Inc.